The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice.
暂无分享,去创建一个
J. Shellito | G. Bagby | D. Stoltz | P. Zhou | O. Prakash | P. Zhang | M. Xie | S. Nelson | M. Ali | R. Coleman | Steve Nelson | Ping Zhang | David A. Stoltz | Om Prakash | Manzoor Ali | Ming Xie | Peng Zhou
[1] G. Warr,et al. Impairment of polymorphonuclear leukocyte immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses. , 2015, The American review of respiratory disease.
[2] B. Joshi,et al. The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. , 1997, Archives of biochemistry and biophysics.
[3] I. Hewlett,et al. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. , 1996, Journal of immunology.
[4] O. Prakash,et al. Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice. , 1996, Journal of immunology.
[5] L. Vaca,et al. Modulation of cell membrane potential in cultured vascular endothelium. , 1996, The American journal of physiology.
[6] I. Hewlett,et al. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. , 1996, Journal of immunology.
[7] R. Chaisson,et al. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. , 1995, Archives of internal medicine.
[8] Ping Zhang,et al. ATTENUATION OF HEPATIC NEUTROPHIL SEQUESTRATION BY ANTI‐CINC ANTIBODY IN ENDOTOXIC RATS , 1995, Shock.
[9] A. Laursen,et al. Decreased activation of the respiratory burst in neutrophils from AIDS patients with previous Pneumocystis carinii pneumonia. , 1995, The Journal of infectious diseases.
[10] R. Gallo,et al. Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. , 1995, Journal of biomedical science.
[11] F. Bistoni,et al. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. , 1995, The Journal of infectious diseases.
[12] M. Dierich,et al. Interaction of several complement proteins with gp120 and gp41, the two envelope gycoproteins of HIV‐1 , 1995, AIDS.
[13] O. Prakash,et al. Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity. , 1994, International journal of immunopharmacology.
[14] S. Capitani,et al. Recombinant human immunodeficiency virus type‐1 (HIV‐1) Tat protein sequentially up‐regulates IL‐6 and TFG‐β1 mRNA expression and protein synthesis in peripheral blood monocytes , 1994, British journal of haematology.
[15] Ping Zhang,et al. HEPATIC NEUTROPHIL SEQUESTRATION IN EARLY SEPSIS: ENHANCED EXPRESSION OF ADHESION MOLECULES AND PHAGOCYTIC ACTIVITY , 1994, Shock.
[16] O. Bagasra,et al. Human studies on alcohol and susceptibility to HIV infection. , 1994, Alcohol.
[17] C. Ambrosino,et al. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein , 1994, The Journal of experimental medicine.
[18] N. Liabakk,et al. Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .
[19] R. Watson,et al. Diet and ethanol modulate immune responses in young C57BL/6 mice. , 1993, Alcoholism, clinical and experimental research.
[20] L. A. Avdeeva,et al. Impact of HIV‐Positive Sera on the Functional Activity of Polymorphonuclear Neutrophils from Healthy Donors , 1993, Scandinavian journal of immunology.
[21] L. Buonaguro,et al. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines , 1992, Journal of virology.
[22] B. Aggarwal,et al. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. , 1992, Lymphokine and cytokine research.
[23] M. Lederman,et al. Suppression of interleukin-2 and interleukin-2 receptor expression in Jurkat cells stably expressing the human immunodeficiency virus Tat protein. , 1992, Cellular immunology.
[24] M. Wulfsohn,et al. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome , 1990 .
[25] C. Pettinelli,et al. Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study. , 1990, Annals of internal medicine.
[26] G. Bagby,et al. The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. , 1989, The Journal of infectious diseases.
[27] M. Cairo,et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. , 1988, The Journal of infectious diseases.
[28] R. Holman,et al. Comparison of Methods for Assessing Chemotaxis of Monocytes and Polymorphonuclear Leukocytes Isolated From Patients With AIDS or AIDS‐Related Conditions , 1988, Journal of leukocyte biology.
[29] C. Maury,et al. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. , 1988, The American journal of medicine.
[30] A. Fauci,et al. Impairment of neutrophil bactericidal capacity in patients with AIDS. , 1988, The Journal of infectious diseases.
[31] D. Linch,et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection , 1987, British journal of haematology.
[32] J. Sodroski,et al. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication , 1986, Cell.
[33] S. Arya,et al. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.
[34] P. Hermans. Clinical use of haematological growth factors in patients with human immunodeficiency virus (HIV-1) infection. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[35] D. Gabrilovich,et al. Clinical significance of neutrophil functional activity in HIV infection. , 1994, Scandinavian journal of infectious diseases.
[36] B. Berkhout,et al. Regulation of HIV expression: mechanisms of action of Tat and Rev. , 1991, AIDS.
[37] G. Bagby,et al. Alcohol suppresses lipopolysaccharide-induced tumor necrosis factor activity in serum and lung. , 1989, Life sciences.
[38] M. Gonda,et al. The trans-activator gene of HTLV-III is essential for virus replication , 1986, Nature.
[39] S. Taniuchi,et al. A quantitative assay of oxidative metabolism by neutrophils in whole blood using flow cytometry. , 1985, Journal of immunological methods.
[40] R. Macgregor,et al. Effect of acute alcohol intoxication on granulocyte mobilization and kinetics. , 1978, Blood.